603259 药明康德
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)11.84618.89020.71814.36111.887
总资产报酬率 ROA (%)8.83413.88714.71210.0527.839
投入资产回报率 ROIC (%)10.10916.07417.20911.6869.067

边际利润分析
销售毛利率 (%)40.65341.17937.29636.28537.992
营业利润率 (%)28.48529.43027.06726.36320.498
息税前利润/营业总收入 (%)28.12928.49226.35126.63323.520
净利润/营业总收入 (%)23.83124.04622.62122.42518.060

收益指标分析
经营活动净收益/利润总额(%)98.47998.31289.97571.94477.377
价值变动净收益/利润总额(%)0.6731.6579.02220.99319.544
营业外收支净额/利润总额(%)-0.466-0.341-0.318-0.368-0.597

偿债能力分析
流动比率 (X)2.3562.0621.6551.6932.911
速动比率 (X)1.9431.7411.2641.2382.572
资产负债率 (%)25.12924.64027.46029.69529.320
带息债务/全部投入资本 (%)11.3219.43711.85911.73010.263
股东权益/带息债务 (%)745.269914.681705.652701.827782.145
股东权益/负债合计 (%)295.757303.673262.277235.136239.406
利息保障倍数 (X)-125.744-33.994-41.82272.5447.482

营运能力分析
应收账款周转天数 (天)77.56361.90648.44765.11071.860
存货周转天数 (天)82.80578.92884.420105.97177.741